Kasai, S., Sasaki, T., Watanabe, A., Nishiya, M., Yasuhira, S., Shibazaki, M., & Maesawa, C. (2017). Bcl-2/Bcl-x(L) inhibitor ABT-737 sensitizes pancreatic ductal adenocarcinoma to paclitaxel-induced cell death. Oncol Lett.

Kasai, Shuya, Takuya Sasaki, Ayano Watanabe, Masao Nishiya, Shinji Yasuhira, Masahiko Shibazaki, and Chihaya Maesawa. "Bcl-2/Bcl-x(L) Inhibitor ABT-737 Sensitizes Pancreatic Ductal Adenocarcinoma to Paclitaxel-induced Cell Death." Oncol Lett 2017.

Kasai, Shuya, et al. "Bcl-2/Bcl-x(L) Inhibitor ABT-737 Sensitizes Pancreatic Ductal Adenocarcinoma to Paclitaxel-induced Cell Death." Oncol Lett 2017.